Nu-Med Plus (NUMD) Amortizatization of Intangibles (2016 - 2022)
Nu-Med Plus (NUMD) reported Amortizatization of Intangibles of $2056.0 for Q3 2022, up 3.06% on a YoY basis from $1995.0 in Q3 2021, and down 33.29% sequentially from $3082.0 in Q2 2022.
Nu-Med Plus (NUMD) Amortizatization of Intangibles (2016 - 2022) Analysis & Trends
Nu-Med Plus (NUMD) has 6 years of Amortizatization of Intangibles data on file, last reported at $2056.0 in Q3 2022.
- For the quarter ending Q3 2022, Amortizatization of Intangibles rose 3.06% year-over-year to $2056.0; the trailing twelve-month figure through Dec 2022 stood at $8222.0 (down 31.55% YoY), and the FY2022 full-year result was $8222.0, down 31.55% from the prior year.
- Amortizatization of Intangibles declined to $2056.0 in Q3 2022, from $3082.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $4030.0 in Q4 2021 to a low of $1995.0 in Q3 2021.
- A 4-year average of $2911.2 and a median of $3022.0 in 2019 frame the typical range for Amortizatization of Intangibles.
- Across the five-year window, Amortizatization of Intangibles soared 54.04% in 2020 and tumbled 35.79% in 2021, its largest moves.
- Tracing NUMD's Amortizatization of Intangibles over 4 years: stood at $3022.0 in 2019, then decreased by 0.93% to $2994.0 in 2020, then soared by 34.6% to $4030.0 in 2021, then slumped by 48.98% to $2056.0 in 2022.
- Business Quant data shows NUMD's Amortizatization of Intangibles at $2056.0 in Q3 2022, $3082.0 in Q2 2022, and $3084.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 2,056.00 |
| Sep 30, 2022 | 2,056.00 |
| Jun 30, 2022 | 3,082.00 |
| Jun 30, 2022 | 3,082.00 |
| Mar 31, 2022 | 3,084.00 |
| Mar 31, 2022 | 3,084.00 |
| Dec 31, 2021 | 4,030.00 |
| Dec 31, 2021 | 4,030.00 |
| Sep 30, 2021 | 1,995.00 |
| Sep 30, 2021 | 1,995.00 |
| Jun 30, 2021 | 2,993.00 |
| Jun 30, 2021 | 2,993.00 |
| Mar 31, 2021 | 2,993.00 |
| Mar 31, 2021 | 2,993.00 |
| Dec 31, 2020 | 2,994.00 |
| Dec 31, 2020 | 2,994.00 |
| Sep 30, 2020 | 3,107.00 |
| Sep 30, 2020 | 3,107.00 |
| Jun 30, 2020 | 3,224.00 |
| Jun 30, 2020 | 3,224.00 |